SLC5A5 and breast carcinoma: The effect of decreased iodide uptake in experimental KT5823-treated breast cancer cell mutants with single or triple mutations of NIS glycosylation sites (N225Q, N489Q, N502Q, N225Q/N489Q/N502Q) showed that the inhibition of iodide uptake was only partly connected with hypoglycosylation of NIS [84].